Advantage Alpha Capital Partners LP Neogenomics Inc Transaction History

Advantage Alpha Capital Partners LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$7.06 - $13.97 $1.2 Million - $2.37 Million	-169,919 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$12.15 - $35.28 $1.41 Million - $4.09 Million	115,972 Added 214.97%	169,919 $2.07 Million
Q4 2021 Feb 14, 2022	BUY	$30.49 - $48.49 $1.64 Million - $2.62 Million	53,947 New	53,947 $1.84 Million

291

124M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.84B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Advantage Alpha Capital Partners LP, based on Form 13F filings with the SEC.

Stay updated on Advantage Alpha Capital Partners LP with notifications on news.